Teleflex Inc. 10-Q Summary: Quarter Ended March 28, 1999
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 28, 1999, for Teleflex Inc., a Delaware corporation. The company operates through three primary segments: Commercial, Medical, and Aerospace. As of the reporting date, there were 37,640,608 shares of Common Stock outstanding.
Key Financial Metrics
| Metric | Q1 1999 | Q1 1998 | |
|---|---|---|---|
| Revenues | $392.2 million | $345.8 million | |
| Net Income | $23.1 million | $19.9 million | |
| Diluted EPS | $0.60 | $0.52 | |
| Gross Margin | 28.3% | 28.9% | |
| Operating Profit | $43.2 million | $39.2 million | |
| Operating Margin | 11.0% | 11.3% | |
| Cash from Operations | $15.0 million | $27.9 million | |
| Long-Term Debt | $270.7 million | $275.6 million (Dec 1998) | |
| Cash & Equivalents | $48.4 million | $66.7 million (Dec 1998) |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 13% year-over-year. Approximately one-third of this growth was attributed to acquisitions, with the remainder driven by internal growth across all segments.
- Profitability: Net income rose 16% and diluted EPS increased 15%. However, gross profit margin declined to 28.3% from 28.9%, and operating margin slipped slightly to 11.0% from 11.3%.
- Cash Flow: Operating cash flow decreased by $13.0 million compared to the prior year, primarily due to increased working capital requirements, specifically a $36.3 million increase in accounts receivable.
- Segment Performance:
- Commercial: Sales up 13%; operating profit up, but margin declined due to new product development costs in the Automotive line.
- Medical: Sales up 12% driven by acquisitions; margin declined due to integration costs and lower initial margins of acquired entities.
- Aerospace: Sales up 15%; margin declined due to a shift in mix toward repairs (shared profits) and declines in cargo systems.
Outlook, Risks, and Management Commentary
- Year 2000 Compliance: The company estimates total remediation costs between $10 million and $12 million. As of March 28, 1999, approximately $8 million has been spent, with over two-thirds of activities completed. The goal is full internal compliance by the third quarter of 1999.
- Risks: Management notes a risk of material adverse effect on operations if significant Year 2000 issues are not corrected, particularly regarding supplier and customer readiness. Diversification across 80+ business units is cited as a mitigating factor.
- Liquidity: The ratio of long-term borrowings to total capitalization improved from 34% to 33% due to increased shareholders' equity.
- Forward-Looking Statements: The report includes assumptions regarding future plans and expectations which are subject to risks and uncertainties.
Investor Verification Checklist
- Verify the sustainability of revenue growth given the 13% increase was partially acquisition-driven.
- Monitor the impact of integration costs on the Medical segment's margins in subsequent quarters.
- Assess the progress of Year 2000 remediation, specifically the readiness of key suppliers and customers.
- Review the trend in accounts receivable, which increased significantly and reduced operating cash flow.
- Confirm the stability of the Automotive product line margins following the reported decline due to new product introductions.